These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 27055598

  • 1. Novel sesquiterpene lactone analogues as potent anti-breast cancer agents.
    Nakagawa-Goto K, Chen JY, Cheng YT, Lee WL, Takeya M, Saito Y, Lee KH, Shyur LF.
    Mol Oncol; 2016 Jun; 10(6):921-37. PubMed ID: 27055598
    [Abstract] [Full Text] [Related]

  • 2. Sesquiterpene Lactone Deoxyelephantopin Isolated from Elephantopus scaber and Its Derivative DETD-35 Suppress BRAFV600E Mutant Melanoma Lung Metastasis in Mice.
    Cvetanova B, Li MY, Yang CC, Hsiao PW, Yang YC, Feng JH, Shen YC, Nakagawa-Goto K, Lee KH, Shyur LF.
    Int J Mol Sci; 2021 Mar 22; 22(6):. PubMed ID: 33810045
    [Abstract] [Full Text] [Related]

  • 3. Phytoagent Deoxyelephantopin and Its Derivative Inhibit Triple Negative Breast Cancer Cell Activity through ROS-Mediated Exosomal Activity and Protein Functions.
    Shiau JY, Chang YQ, Nakagawa-Goto K, Lee KH, Shyur LF.
    Front Pharmacol; 2017 Mar 22; 8():398. PubMed ID: 28706483
    [Abstract] [Full Text] [Related]

  • 4. A Novel Plant Sesquiterpene Lactone Derivative, DETD-35, Suppresses BRAFV600E Mutant Melanoma Growth and Overcomes Acquired Vemurafenib Resistance in Mice.
    Feng JH, Nakagawa-Goto K, Lee KH, Shyur LF.
    Mol Cancer Ther; 2016 Jun 22; 15(6):1163-76. PubMed ID: 27048951
    [Abstract] [Full Text] [Related]

  • 5. Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice.
    Huang CC, Lo CP, Chiu CY, Shyur LF.
    Br J Pharmacol; 2010 Feb 22; 159(4):856-71. PubMed ID: 20105176
    [Abstract] [Full Text] [Related]

  • 6. Phytoagent deoxyelephantopin derivative inhibits triple negative breast cancer cell activity by inducing oxidative stress-mediated paraptosis-like cell death.
    Shiau JY, Nakagawa-Goto K, Lee KH, Shyur LF.
    Oncotarget; 2017 Aug 22; 8(34):56942-56958. PubMed ID: 28915644
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-Mediated Mitochondrial Dysfunction Is Involved in the Anti-triple-Negative Breast Cancer Cell Activity of Phytosesquiterpene Lactones.
    Cheng YT, Nakagawa-Goto K, Lee KH, Shyur LF.
    Antioxid Redox Signal; 2023 Jan 22; 38(1-3):198-214. PubMed ID: 35850524
    [Abstract] [Full Text] [Related]

  • 8. Phyto-sesquiterpene lactone deoxyelephantopin and cisplatin synergistically suppress lung metastasis of B16 melanoma in mice with reduced nephrotoxicity.
    Chao WW, Cheng YW, Chen YR, Lee SH, Chiou CY, Shyur LF.
    Phytomedicine; 2019 Mar 15; 56():194-206. PubMed ID: 30668340
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic impact of Nintedanib with paclitaxel and/or a PD-L1 antibody in preclinical models of orthotopic primary or metastatic triple negative breast cancer.
    Reguera-Nuñez E, Xu P, Chow A, Man S, Hilberg F, Kerbel RS.
    J Exp Clin Cancer Res; 2019 Jan 11; 38(1):16. PubMed ID: 30635009
    [Abstract] [Full Text] [Related]

  • 10. Budlein A methylacrylate demonstrates potent activity against triple-negative breast cancer by targeting IκBα kinase and exportin-1.
    Wang XZ, Feng Y, Han YF, Bian Y, Liang J, Wen HM, Wu H.
    Toxicol Appl Pharmacol; 2020 Dec 01; 408():115263. PubMed ID: 33022283
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
    Elkhalifa D, Siddique AB, Qusa M, Cyprian FS, El Sayed K, Alali F, Al Moustafa AE, Khalil A.
    Eur J Med Chem; 2020 Feb 01; 187():111954. PubMed ID: 31838326
    [Abstract] [Full Text] [Related]

  • 12. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
    Hsieh MT, Chang LC, Hung HY, Lin HY, Shih MH, Tsai CH, Kuo SC, Lee KH.
    Eur J Med Chem; 2017 May 05; 131():141-151. PubMed ID: 28319780
    [Abstract] [Full Text] [Related]

  • 13. AMG 900, a small-molecule inhibitor of aurora kinases, potentiates the activity of microtubule-targeting agents in human metastatic breast cancer models.
    Bush TL, Payton M, Heller S, Chung G, Hanestad K, Rottman JB, Loberg R, Friberg G, Kendall RL, Saffran D, Radinsky R.
    Mol Cancer Ther; 2013 Nov 05; 12(11):2356-66. PubMed ID: 23990115
    [Abstract] [Full Text] [Related]

  • 14. Isodeoxyelephantopin, a Sesquiterpene Lactone Induces ROS Generation, Suppresses NF-κB Activation, Modulates LncRNA Expression and Exhibit Activities Against Breast Cancer.
    Verma SS, Rai V, Awasthee N, Dhasmana A, Rajalaksmi DS, Nair MS, Gupta SC.
    Sci Rep; 2019 Nov 29; 9(1):17980. PubMed ID: 31784542
    [Abstract] [Full Text] [Related]

  • 15. Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.
    Shetti D, Zhang B, Fan C, Mo C, Lee BH, Wei K.
    Cells; 2019 Aug 14; 8(8):. PubMed ID: 31416135
    [Abstract] [Full Text] [Related]

  • 16. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS, Ho Y, Lin YW, Naveen Raj E, Liu KK, Chen C, Zhou XZ, Lu KP, Chao JI.
    Acta Biomater; 2019 Mar 01; 86():395-405. PubMed ID: 30660004
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
    Lee J, Lim B, Pearson T, Choi K, Fuson JA, Bartholomeusz C, Paradiso LJ, Myers T, Tripathy D, Ueno NT.
    Breast Cancer Res Treat; 2019 Jun 01; 175(2):339-351. PubMed ID: 30826934
    [Abstract] [Full Text] [Related]

  • 18. Deoxyelephantopin impedes mammary adenocarcinoma cell motility by inhibiting calpain-mediated adhesion dynamics and inducing reactive oxygen species and aggresome formation.
    Lee WL, Shyur LF.
    Free Radic Biol Med; 2012 Apr 15; 52(8):1423-36. PubMed ID: 22342517
    [Abstract] [Full Text] [Related]

  • 19. Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer.
    Speyer CL, Bukhsh MA, Jafry WS, Sexton RE, Bandyopadhyay S, Gorski DH.
    Breast Cancer Res Treat; 2017 Nov 15; 166(2):407-419. PubMed ID: 28780701
    [Abstract] [Full Text] [Related]

  • 20. Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer.
    Zheng MW, Zhang CH, Chen K, Huang M, Li YP, Lin WT, Zhang RJ, Zhong L, Xiang R, Li LL, Liu XY, Wei YQ, Yang SY.
    Mol Cancer Ther; 2016 Mar 15; 15(3):366-78. PubMed ID: 26721945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.